PTGS2 and neoplasm: Inhibitors of fatty acid synthesis, such as FASN inhibitors, or drugs that modulate lipid signaling pathways, such as cyclooxygenase-2 (COX-2) inhibitors, could be used to disrupt the metabolic adaptations that support tumor growth and inflammation [58].